
|
Loading...
Loading...
US Pharm. 2012;37(2):10.
Nashville, TN—According to a recent study published in Neurology, people with mild cognitive impairment may benefit from the use of a transdermal nicotine patch. The study involved 74 people with an average age of 76 years who had mild cognitive impairment and were not smokers. Half of the participants received a nicotine patch of 15 mg per day and half received a placebo. After 6 months of treatment, the nicotine-treated group regained 46% of normal performance for age on long-term memory, whereas the placebo group worsened by 26%. “This study provides strong justification for further research into the use of nicotine for people with early signs of memory loss,” said researcher Paul Newhouse, MD, of Vanderbilt University School of Medicine in Nashville.
To comment on this article, contact rdavidson@uspharmacist.com.
|
Loading...
Loading...
|
|
U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date,
authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings,
including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations,
long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students,
other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn
Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE)
as a provider of continuing pharmacy education.
Copyright © 2000 - 2013 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.
|